Emerging evidence indicates that polychlorinated biphenyls (PCBs) are involved in the development of diabetes mellitus in the obese. The purpose of this study was to determine mechanisms by which PCB 153 (2,2′,4,4′,5,5′-hexachlorobiphenyl) could influence diet-induced obesity and insulin resistance during adipogenesis. Lineage of h-ADMSCs was differentiated either as control (differentiation medium only), or with lipid vehicle modeling high fat nutrition (NuTRIflex) or lipid free vehicle (dimethylsulfoxide) for 28 days with or without PCB 153 daily co-exposure (in three concentrations 0.1, 1, and 10 µM). Gene expression analyses were performed using RT-qPCR at days 4, 10, 21, 24, 28; protein levels Akt and phosphorylated Akt (Phospho-Akt) by Western blot at days 4, and 21. PCB 153 treatment of h-ADMSCs only in lipid vehicle was associated with down regulation of key master genes of adipogenesis: PPARγ, SREBP-1, PPARGC1B, and PLIN2 during the whole process of differentiation; and with increased Akt and decreased Phospho-Akt protein level at day 21. We have shown that PCB 153, in concentration 0.1 µM, has a potential in lipid rich environment to modulate differentiation of adipocytes.
Introduction
Obesity is a rapidly growing pandemic. Visceral obesity is often seen in association with hypertension, dyslipidemia, insulin resistance and, type 2 diabetes mellitus (T2DM). T2DM is a complex condition resulting from the interaction between genetic and environmental factors, especially from unhealthy diets and decreased physical activity. However, emerging evidence from epidemiologic studies has also suggested the contribution of some environmental contaminants, including polychlorinated biphenyls (PCBs) to the observed Vol. 66 growing T2DM (Lee et al. 2006) , and the metabolic syndrome (Lee et al. 2007) . PCBs are polyhalogenated aromatic hydrocarbons consisting of up to 10 chlorine atoms attached to a biphenyl group. A total of 1.3 million tons of PCBs consisting of 130 individual congeners were manufactured prior 1977 (Breivik et al. 2002) for use in electrical and other industrial applications. In the former Czechoslovakia, PCB were marketed as technical mixtures under the trade name "Delor" and were produced in the amount of about 21.500 tons in Eastern Slovakia from 1959 to 1984, when the production was finally abolished (Pavuk et al. 2004) . About 11.600 tons of this amount were used inside the former Czechoslovakia (Cerna et al. 2008) . Unfortunately, thanks to this inheritance, the industrial areas of the Czech Republic have one of the highest PCB burdens of all Europe (Cerna et al. 2010) . Although PCBs production and sale have been banned in many industrial countries for over 30 years, they are resistant to biodegradation and thus continue to be present in the diet however their exposure is continuously decreased. Contaminated food, especially fatty fish, meat and milk products, is still a main source of their exposure to general population.
Their concentration in human tissue is generally monitored by using examinations of human breast milk and also data from Europe showing their decreased concentration. 138, and 180 are the main congeners which show the highest concentration and are most frequently found in breast milk (Bencko et al. 1998) . As well all of American adult NHANES participants had detectable circulating PCB levels in humans and PCB 153 has the highest median serum concentration of any single congeners (Cave et al. 2010) .
Adipose tissue is a main storage site for many lipophilic persistent organic pollutants, including PCBs. Their structure determines their ability to interact with nuclear receptors, and thus they may modulate differentiation, metabolism, and secretory functions of adipose tissue (see review Mullerova and Kopecky 2007) .
The effect of PCB 153, has not been adequately studied in models of adipocyte differentiation, likewise, in models with nutrient-toxicant interactions, which appear to be important in diet-induced obesity/metabolic syndrome (Hennig et al. 2007) .
The purpose of this study is i) to determine, in a model of differentiating adipocytes, if PCB 153 chronic exposure itself is sufficient to alter expression of genes involved in adipocyte maturation; and ii) to determine if PCB 153 diluted in lipid vehicle simulating fatty diet worsens differentiation of adipocytes and their function by exacerbating previously implicated mechanisms such as insulin resistance.
Materials and Methods
In order to verify a hypothesis that PCB 153 may modify differentiation of adipocytes, and their function, expression of selected genes by RT real-time PCR and proteins by Western blot as markers of differentiation and insulin sensitivity were measured in a cell culture of human adipose derived mesenchymal stem cells (h-ADMSCs), which were differentiated either control (differentiation medium only, DM) or with lipid vehicle NuTRIflex (LV), or with dimethylsulfoxide vehicle (SV) for 28 days with or without PCB 153 daily co-exposure (in three concentrations 0.1 µM, 1 µM, and 10 µM). Monitoring of gene expression was performed at days 4, 10, 21, 24, 28 of differentiation.
Cell culture differentiation and PCB 153 treatment
h-ADMSCs, isolated from a single female donor from subcutaneous adipose tissue and characterized by flow cytometry were obtained from the Invitrogen (Invitrogen Life Technologies GmbH, Darmstadt, Germany) and cultured in 6-well plate (TPP Techno Plastic Products, Switzerland) in commercially available culture medium MesenPRO RS™ Medium supplemented with MesenPRO RS™ Growth Supplement with reduced serum level (2 %), 1 % L-glutamine and 1 % Gentamicine (all Invitrogen Life Technologies GmbH, Darmstadt, Germany).
For adipogenic differentiation, h-ADMSCs were seeded with a total number of 1 x 105 cells in a 6-well cell culture plate and cultured according to the manufacturer's instructions in StemPro® Adipogenesis Differentiation medium supplemented with 1 % Gentamicine. The medium was changed every 3 days up to a total incubation time of 28 days.
The cells were maintained and cultured into differentiated adipocytes under 5 % CO 2 atmosphere at 37 °C. Cells were incubated either control DM, containing insulin 1250 IU/l (glucose 23 mM, cholesterol 0.37 mM, triacylglyceroles (TG) 0.08 mM), or DM with SV or DM with LV (high fat medium, imitative high fat diet, NuTRIflex® Lipid peri: glucose 23 mM, cholesterol 0.35 mM, TG 1.069 mM). PCB 153 (Sigma Aldrich, St. Louis, MO, USA), was administered either in LV or in SV at three different concentrations (0.1 µM, 1 µM, and 10 µM) vs. controls (DM, DM+LV, DM+SV). A gene expression analyses were performed at days 4, 10, 21, 24 and 28. Thus nine different treatment groups were evaluated in this fashion: DM, DM+LV, DM+SV, DM+LV+PCB 153-0.1 µM, DM+LV+PCB 153-1 µM, DM+LV+PCB 153-10 µM, DM+SV+PCB 153-0.1 µM, DM+SV+PCB 153-1 µM, DM+SV+PCB 153-10 µM.
Real time-PCR
Total RNA was isolated from a pellet of cells (approximately 10 6 cells) by FastRNAPro Green Kit (QBIOgene, Irvine, CA, USA). Reverse transcription (RT) was performed from 250 ng of total RNA with Superscript III Reverse Transcriptase (Life Technologies, Carlsbad, CA, USA) and random hexamers as primers. Table 1 shows the sequences of primers and corresponding UPL probes generated by ProbeFinder Software (Roche, Mannheim, Germany). The primers were synthesized by East Port Praha (Prague, Czech Republic). A quantitative estimation was performed in technical duplicates using UPL probes (Table 1) on Stratagene Mx3005P apparatus (Agilent Technologies, Inc., Santa Clara, CA, USA). All samples were also assessed for the expression of reference genes GUSB, HPRT, YWHAZ. Selection of the most suitable reference genes was done prior to the study (unpublished data). The results are presented as normalized values (2 -ΔΔCt algorithm) using geometric mean of quantification (Ct) of three reference genes (GUSB, HPRT, YWHAZ) (Kozera and Rapacz 2013).
Determination of Phospho-Akt/Akt by Western blot
On days 4 and 21, cells were lysed with M-PER Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, Waltham, MA, USA) containing protease inhibitor cocktail (cOmplete Protease Inhibitor Cocktail Tablets, Roche, Basel, Switzerland) and phosphatase inhibitor cocktail (PhosSTOP Phosphatase Inhibitor Cocktail Tablets, Roche, Basel, Switzerland). The protein was quantified using Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA) and 3 μg aliquots of protein were electrophoresed by SDS-PAGE and transferred to Immun-Blot PVDF membranes (Bio-Rad, Hercules, CA, USA).
Protein levels of Akt and Phospho-Akt were determined by PhosphoPlus Akt (Ser473) Antibody Duet kit (Cell Signaling Technologies, Danvers, MA, USA) containing primary antibodies Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb (used in 1:2000 dilution) and AktT (pan) (C67E7) Rabbit mAb (used in 1:1000 dilution). Anti-rabbit IgG, HRP-linked Antibody (1:1000 dilution; Cell Signaling Technologies, Danvers, MA, USA) was used as a secondary antibody. For an internal control and purpose of relative quantification, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was detected by GAPDH (14C10) Rabbit mAb (1:2000 dilution; Cell Signaling Technologies, Danvers, MA, USA).
Immune complexes were visualized using WesternBright ECL HRP substrate (Advansta, Menlo Park, CA, USA) and the luminescent signal was detected and relative band intensity was analyzed with a digital documentation system and software Alliance 4.7 (UVItec, Cambridge, UK).
Statistical analysis
Statistical analyses were performed using Matlab Statistics Tool Box version R2012a for Windows. Non-parametric Wilcoxon two-sided signed-rank test was performed for statistical analysis. P-value less than 0.05 was considered statistically significant.
Also non-parametric Friedman`s test was performed for statistical analyses of genes expression during the monitored days of differentiation between by PCB 153 exposed cells and controls. Friedman`s test was calculated to assess whether there was a significant effect of the particular concentrations of PCB 153 on the temporal changes in gene expression.
Results

PCB 153 treatment altered mRNA expression of genes involved in differentiation of adipocytes cultured in LV, but had no effect on adipocytes cultured in SV in comparison to a control with DM only
Gene expression was assessed in h-ADMSCs during the process of differentiation to analyze potential changes in expression of selected genes keeping cells in pluripotent state -OCT4 (octamer-binding transcription factor 4), NANOG (nanog homeobox). PCB 153 treatment altered these gene expressions only in differentiating adipocytes cultivated in LV+DM, where NANOG gene expression in LV+DM+PCB 153 (0.1 and 1 µM) was significantly decreased vs. both LV+DM or DM (p<0.05), but had no effect in SV+DM. OCT4 gene Vol. 66 expression was altered by PCB 153 depending on concentration, while 0.1 µM reduced, and 1 µM increased OCT4 expression (p<0.05). There was no statistical difference between DM and PCB treated cell cultures in expression of SOX2.
PCB 153 exposure altered gene expression of mRNA of proteins involved in lipid storage in ongoing process of differentiation PLIN 2 (perilipin 2) expression was decreased in LV+DM+PCB 153 (0.1 µM) vs. LV+DM (p<0.05). Although there was a non-significant trend towards higher PLIN 2 expression in LV vs. DM (p=0.13) we have seen the similar pattern in dichlorodiphenyl dichloroethylene (DDE) exposure (Mullerova et al. 2016) , where LV+DM increased expression of PLIN 2 vs. DM, and this increase was stifled by DDE exposure (Mullerova et al. 2016) . No alterations were seen in PCB 153 co-exposure in SV+DM.
PCB 153 exposure down-regulated gene expression of main regulators of adipogenesis PPARγ, SREBP-1, and PPARGC1B
PPARγ (peroxisome proliferator-activated receptor γ) is a member of the nuclear receptor superfamily of ligand activated transcription factors. It is highly expressed in adipose tissue and it seems to be a main regulator of adipogenesis (Ni et al. 2013) . PPARγ expression was in comparison to DM significantly decreased in LV+DM and in LV+DM+PCB 153 in concentrations 10 µM and 0.1 µM vs. DM (p<0.05), moreover there was a significant difference between LV+DM and LV+DM+PCB 153 in concentration 0.1 µM, where this concentration further intensified reduction of PPARγ gene expression ( Fig. 1) .
SREBP-1 (sterol regulatory element-binding protein-1) is also involved in adipogenesis. PCB 153 in concentrations 0.1 and 1 µM reduced gene expression of SREBP-1 in comparison to DM (p<0.05) or to LV+DM, however in case of concentration 0.1 µM only at p value 0.07. There was a significant difference in SREBP-1 expression between LV+DM and DM (p<0.05) (Fig. 1) .
Expression of PPARGC1B (peroxisome proliferator-activated receptor γ coactivator 1β) mRNA which is induced during white and brown adipocyte differentiation, and regulates mitochondrial oxidative metabolism, was significantly decreased in LV+DM+PCB 153 in concentrations 10 and 0.1 µM vs. DM (p<0.05) (Fig. 1) . PPARGC1B mRNA is highly responsive to environmental cues and coordinate metabolic gene programs through interaction with transcription factors and chromatin-remodeling proteins.
LV, but not PCB 153 exposure altered gene expression of enzymes involved in adipocyte lipid metabolism
There were also evident alterations in gene expression of enzymes involved in fatty acids de novo synthesis (FASN, fatty acid synthase) and gene implicated in TG lipolysis by hormone-sensitive lipase (LIPE), under LV+DM treatment vs. DM, however without any additional effects of PCB 153 exposure. FASN and LIPE gene expressions were statistically significantly decreased in LV+DM and LV+DM+ PCB 153 in all examined concentrations (0.1 µM, 1 µM, and 10 µM), in comparison to DM, however there was not a statistical difference between LV+DM and LV+DM+PCB exposed cultures. Transcription of FASN gene can be activated by stimulatory factors acting through SREBP-1.
PCB 153 exposure altered gene expression of proteins involved in adipocyte glucose metabolism and insulin sensitivity
No significant differences were seen in INSR (insulin receptor) or in AKT2 (protein kinase B) genes expression, apart from a statistical difference between LV+DM+PCB 153, in 0.1 µM vs. LV+DM where the expression is significantly lower (p<0.05).
There were not found any differences in expression of ACLY (ATP citrate lyase) gene after exposure of PCB 153 in comparison to DM or DM+LV or DM+SV.
PCB 153 altered Phospho-Akt levels and Phospho-Akt/Akt measured by Western blot although the effect is opposite at day 4 and 21 of ongoing differentiation
Although Akt gene expression in LV+DM, and much more in all three PCB 153 concentrations, especially in 0.1 µM and 1 µM co-exposed cultures, was reduced in comparison to DM on day 4 of differentiation, Phospho-Akt levels were doubled in LV+DM and in all these co-exposed cultures in comparison to DM. However, on day 21 it was completely vice versa. Relation of Phospho-Akt to Akt was higher on day 4, and lower on day 21 in LV+DM, and more profound PCB in PCB 153 co-exposed cultures than DM, once again especially in concentrations 0.1 and 1 µM (Fig. 2) . Vol. 66 Table 1 . Primer sequences for quantitative reverse transcription polymerase chain reaction (qRT-PCR) with Universal Probe Library probes.
Symbol
Gene name
Function
Primer sequence 5´-3´ 
UPL probe
Reference genes GUSB
C TTC GC G TG TT G CCC AGGA CT G G T TTG GCT A T G C C T T 3
Discussion
PCBs are known to concentrate within adipose tissue. Our aim was to evaluate effects of chronic exposure of h-ADMSCs to PCB 153 during the ongoing process of differentiation.
Chronic toxicity in this study was monitored by morphology, differentiation potential towards adipogenic lineage, and especially by expression analysis of 13 genes, taking part in differentiation and as well in functions of maturated adipocytes, and the level of active Akt protein (Phospho-Akt).
PCB 153 levels were similar to those found in human lipid adjusted serum 10-1260 ng/g (Mullerova et al. 2015) . Therefore, the PCB 153 dose in our study reflected the serum levels observed in obese human populations.
Adipogenesis and lipogenesis are governed by a vast number of enzymes that act together along with key hormones and metabolites to regulate fat cell metabolism. Differentiation of h-ADMSCs, adipocyte precursors, is driven by a cascade of events controlled by transcription regulators, coactivators, and cell-cycle controls. This entire process is closely regulated at the transcriptional level.
h-ADMSCs were induced to differentiate in vitro by means of DM containing an external cue, such as insulin, glucocorticoids and/or molecules that can increase intracellular cAMP. These cues trigger the beginning of a transcriptional cascade composed of a network of proteins that mediate the functions of adipocytes.
We did not observe any effect of PCB 153 on adipogenesis in the absence of high fat vehiculum/feeding, however, there were alterations of gene expressions in case of fat vehiculum with PCB 153. Similarly Wahlang et al. (2013) documented that PCB 153 is a relevant "second hit" mechanism in the genesis and progression of obesity occurring in the context of a high fat diet. In consistency with findings of a meta-analysis within 12 European Birth Cohorts, where a low-level exposure to PCB was inversely associated with fetal growth (Govarts et al. 2012) , in our study the concentration of PCB 153 at lower concentration 0.1 µM and 1 µM, had the more profound effect on adipogenesis in comparison to the highest tested concentration 10 µM. Similarly a non-linear pattern between persistent organic pollutants exposure and serum lipids/obesity has been shown (Arrebola et al. 2014) .
At the beginning of differentiation h-ADMSCs expressed pluripotency genes OCT4, SOX2, NANOG. They are down-regulated with the ongoing process of differentiation. We observed faster down-regulation of NANOG as effects of PCB 153, in concentration 0.1 µM, diluted in fat vehicle. It may be a stimulus to differentiation to adipocyte and loss of pluripotency of mesenchymal stem cells under PCB 153 treatment.
FASN is highly expressed in lipogenic tissues such as adipose tissue, liver, lactating breast. It is a key enzyme in the de novo synthesis of long-chain fatty acids starting with acetyl coenzyme A and malonylcoenzyme A using NADPH as a reducing factor. The observed lower levels of FASN expression in our study are determined because cells obtained their needed fatty acids from fat vehiculum, rather than from lipogenesis, as occurs in normal cells. FASN provides saturated lipids for membrane synthesis, increased saturated lipid content in the membranes. FASN expression and activities are up-regulated by androgens and epidermal growth factor. However, we were not able to show any additional effects to fat vehiculum, although PCB 153 shows a weak antiandrogenic effect. FASN has been implicated in diabetes and cancer development. It also can be overexpressed through an activation of the PI3K/Akt pathway.
LIPE catalyzes both the release of fatty acids from storage triglycerides in adipocytes and the liberation of cholesterol from cholesterol esters in steroidogenic tissues. LIPE activity is regulated in a tissue-, development-and hormone-specific fashion, the latter in large part by serine phosphorylation (Sztrolovics et al. 1997) . Similarly to FASN, there was a down-regulation of LIPE after the treatment of fat vehiculum or fat vehiculum with PCB 153, with no differences between them.
PPARγ, a member of the nuclear receptor superfamily of ligand activated transcription factors, represents one of the key regulatory elements taking part in proliferation of precursor's cells and their differentiation into mature adipocytes. Its activation by various ligands (such as fatty acids and eicosanoids) sets in the run the transcription process promoting adipocyte differentiation. The level of PPARγ protein peaks soon after differentiation and remains high in mature adipocytes. Thus PPARγ functions as a cellular sensor for nutritional fatty acids which, in mature adipocytes, is capable of transducing metabolic signals into the transcriptional control of genes involved in insulin Vol. 66 signaling, glucose and fatty acids metabolism. In response to energy overfeeding, the expression of PPARγ rather than SREBP1 was closely associated with most adipogenic or lipogenic genes (Ji et al. 2014) . In our study PPARγ expression was significantly down-regulated in lipid vehicle and still more after exposure to PCB 153 in concentration 0.1 µM. Consistent with our results de novo lipogenesis pathway has been demonstrated to be repressed in obese, insulin-resistant adipose tissue of both humans and rodens however with cytokine-mediated suppression of PPARγ and SREBP1 (Zhang et al. 1996 , Sewter et al. 2002 , Tang et al. 2006 , Ye 2008 , Keuper et al. 2013 . PPARγ is required for activation of the lipolytic regulatory network, dysregulation of which is an important feature of obesity-induced insulin resistance in humans. Defective PPARγ impairs catecholamineinduced lipolysis. This abnormal lipolytic response is exacerbated by a state of positive energy balance in leptin-deficient ob/ob mice (Rodriguez-Cuenca et al. 2012) . Defective PPARγ is associated with decreased basal expression of the lipase genes PNPLAZ (ATGL) and LIPE (HSL), and lipid droplet protein genes FSP27 and PLIN 2 in vivo and in vitro. Only few studies based on preadipocytes model have shown that PCBs, especially dioxin like PCBs as PCB 126 have potential by the way of AhR activation to inhibit PPARγ transcription and subsequent adipogenesis (Gadupudi et al. 2015) .
MiRNA and its host gene PPARGC1B are primary PPARγ targets in adipocytes (John et al. 2012) . MiRNA can induce lipogenesis and expression of lipogenic genes, when overexpressed during adipogenesis of mesenchymal precursors (Takada et al. 2009 ). PPARGC1B is a known transcriptional co-activator responsible for inducing the target genes of numerous transcription factors that are involved in regulation of lipogenesis and related processes (Lin et al. 2005 , Ortega et al. 2010 .
The Akt (protein kinase B) pathway is a signal transduction pathway that promotes the survival and growth in response to extracellular signals. Activatedphosphorylated Akt mediates downstream responses, including cell survival, growth, proliferation, cell migration and angiogenesis, by phosphorylating a range of intracellular proteins.
The pathway is highly regulated by multiple mechanisms, often involving cross-talk with other signaling pathways. Problems with PI3K-Akt pathway regulation have been linked to a range of diseases such as cancer and T2DM. Akt phosphorylates as many as 100 different substrates, leading to a wide range of effects on the cell. For example increased insulin signaling at Akt signaling node may lead to reduced insulin sensitivity at endothelial nitric oxide synthase (eNOS) signaling code (Kearney 2013). The extremes of insulin sensitivity both impact unfavourably on endothelian cell function. Our study showed an increased Akt level and decreased Phospho-Akt level, measured by Western blot, at day 21 of ongoing process of differentiation because of added lipid vehicle; however these changes were more profound after PCB 153 co-exposure, especially in 0.1 µM and 1 µM concentrations. Due to that fact the relation of Phospho-Akt to Akt was reduced once again especially in concentrations 0.1 and 1 µM.
In conclusion, this study gives us a molecular insight of PCB 153 induced changes in gene expression with a special reference to differentiation process in the h-ADMSCs line which leads to the mature adipocytes. These changes are visible only in fat (nutrient toxic) environment and are associated especially with down-regulation of key master genes of adipogenesis and pAkt level. Dysfunctional adipocytes play a significant role in initiating insulin resistance. Preadipocytes make up a large portion of adipose tissue and are necessary for the generation of functional mature adipocytes through adipogenesis.
transcription factor 4, pAkt -phosphorylated Akt, PCBs -polychlorinated biphenyls, PCR -polymerase chain reaction, PI3K/AKT -phosphatidylinositol 3-kinase/AKT pathway, PLIN2 -perilipin 2, PPARγperoxisome proliferator-activated, receptor gamma,
PPARGC1B
peroxisome proliferator-activated receptor γ coactivator 1β, SOX2 -SRY-box 2, SREBP-1 -sterol regulatory element-binding protein-1, SV -lipid free vehicle-dimethylsulfoxid, T2DM -type 2 diabetes mellitus.
